IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,408,000 | +48.3% | 251,371 | +70.9% | 0.01% | +50.0% |
| Q2 2022 | $1,624,000 | +242.6% | 147,121 | +416.9% | 0.00% | +300.0% |
| Q1 2022 | $474,000 | -90.2% | 28,460 | -88.8% | 0.00% | -88.9% |
| Q4 2021 | $4,839,000 | +1.2% | 253,480 | +30.8% | 0.01% | -10.0% |
| Q3 2021 | $4,780,000 | +397.9% | 193,814 | +425.2% | 0.01% | +400.0% |
| Q2 2021 | $960,000 | -17.9% | 36,905 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $1,169,000 | -34.4% | 36,905 | -3.8% | 0.00% | -25.0% |
| Q4 2020 | $1,781,000 | +38.8% | 38,365 | -1.6% | 0.00% | +33.3% |
| Q3 2020 | $1,283,000 | +70.4% | 38,975 | +42.1% | 0.00% | +50.0% |
| Q2 2020 | $753,000 | -8.3% | 27,419 | 0.0% | 0.00% | -33.3% |
| Q1 2020 | $821,000 | +47.1% | 27,419 | +36.2% | 0.00% | +200.0% |
| Q4 2019 | $558,000 | – | 20,134 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |